Nanoviricides Inc's ROI from its fourth quarter of 2026 to the fourth quarter of 2025 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Nanoviricides Inc's ROI in the fourth quarter of 2026?
Nanoviricides Inc recorded a cumulative net loss of $-8 million during 12 months ending in the fourth quarter of 2026, resulting in a negative return on investment (ROI) of -101.03%.

Within the Healthcare sector 634 other companies had a higher return on investment. While return on investment, the total ranking has deteriorated compared to the third quarter of 2026 from 3628 to 3816.

Definition and Formula of Return on Investment

Select the Comparisons :

None ▼

Select the Ratio:

Return on Investment ROI▼

None ▼

Return on Investment ROI▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

Return On Investment	(Jun 30 2026) IV. Quarter	(Mar 31 2026) III. Quarter	(Dec 31 2025) II. Quarter	(Sep 30 2025) I. Quarter	(Jun 30 2025) IV. Quarter
Y / Y Investment Change TTM	-14.2 %	-25.09 %	-28.94 %	-27.99 %	-28.38 %
Y / Y Net Income Change TTM	-	-	-	-	-
Investment (TTM) in Millions	9	9	8	7	8
Return On Investment (TTM)	-101.03 %	-103.19 %	-107.19 %	-92.89 %	-99.86 %
NNVC's Overall Ranking	# 3816	# 3628	# 2962	# 3651	#
Seq. Investment Change TTM	3.75 %	1.03 %	-11.28 %	-7.73 %	-9.43 %
Seq. Net Income Change TTM	-	-	-	-	-
Net Income (TTM) in Millions	-8	-8	-8	-8	-9

NNVC Company Profile >> Back to NNVC Roi Comparisons >> See Annual NNVC Return On Investment

Return On Investment NNVC's Ranking
Within:	No.
Industry	# 292
Sector	# 635
Overall	# 3816

Return On Investment Statistics
High	Average	Low
-4.68 %	-52.01 %	-131.66 %
(Jun 30 2015)		(Mar 31 2020)

Financial Statements
Nanoviricides Inc's IV. Quarter Investments	$ 9 Millions	NNVC's Balance sheet
Nanoviricides Inc's IV. Quarter Income	$ -2 Millions	Quarterly NNVC's Income Statement
NNVC's Income by Division		See NNVC's Income by Division

NNVC Annual Return On Investment	(Jun 30 2026) 2026	(Jun 30 2025) 2025	(Jun 30 2024) 2024	(Jun 30 2023) 2023	(Jun 30 2022) 2022
Total Investments in Millions	9	8	11	16	23
Y / Y Investment Growth	15.62 %	-34.43 %	-29.95 %	-29.39 %	-22.76 %
Net Income in Millions	-8	-9	-8	-9	-8
Y / Y Net Income Growth	-	-	-	-	-
Annual Return On Investment	-94.55 %	-125.93 %	-72.35 %	-52.48 %	-34.98 %

Annual Roi Comment

Definition and Formula of Return on Investment

Other ROI Ratios
Major Pharmaceutical Preparations Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
NNVC's Roi Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for NNVC's Competitors
Subscribers only: Roi for Nanoviricides Inc's Suppliers
Subscribers only: Return On Investment for NNVC's Customers

Other Ratios
NNVC's Roa	NNVC's Inventory Turnover Ratio	NNVC's Growth Rates	NNVC's Dividend Statistics
	NNVC's Profitability Ratios	NNVC's Asset Turnover Ratio	NNVC's Dividend Growth
NNVC's Roe	NNVC's Valuation Ratios	NNVC's Financial Strength Ratios	NNVC's Dividend Payout Ratio

Companies with similar Return On Investment at Jun 30 2026, within Healthcare Sector

ROI

Date modified: 2026-09-29T04:37:54+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.